Paola Gonzalo-Encabo1,2,3, Jessica McNeil1,4, Alberto Pérez-López2, David Valadés2, Kerry S Courneya5, Christine M Friedenreich6,7,8. 1. Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada. 2. Department of Biomedical Sciences, Area of Sport and Physical Education (GRIGEDE), University of Alcalá, Alcalá de Henares, Madrid, Spain. 3. Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain. 4. Department of Kinesiology, School of Health and Human Sciences, University of North Carolina Greensboro, Greensboro, NC, USA. 5. Faculty of Kinesiology, Sport and Recreation, University of Alberta, Edmonton, AB, Canada. 6. Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada. christine.friedenreich@ahs.ca. 7. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. christine.friedenreich@ahs.ca. 8. Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. christine.friedenreich@ahs.ca.
Abstract
BACKGROUND/ OBJECTIVE: Exercise may reduce the risk of breast cancer through adiposity changes, but the dose-response effects of exercise volume on adiposity markers are unknown in postmenopausal women. We aimed to compare the dose-response effects of prescribed aerobic exercise volume on adiposity outcomes. PARTICIPANTS/ METHODS: Data from the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) and Breast Cancer and Exercise Trial in Alberta (BETA) were pooled for this analysis (N = 720). These were 12-month randomized controlled trials, where participants were randomized to 225 min/week (mid-volume) of aerobic exercise versus usual inactive lifestyle (ALPHA), or 150 min/week (low-volume) versus 300 min/week (high-volume) (BETA). Fat mass and fat-free mass were measured using DXA and intra-abdominal and subcutaneous fat area were assessed with computed tomography. RESULTS: After 12 months of aerobic exercise, increasing exercise volumes from no exercise/control to 300 min/week resulted in statistically significant reductions in BMI, weight, fat mass, fat percentage, intra-abdominal and subcutaneous fat area (P < 0.001). Compared with controls, fat mass loss was -1.13, -1.98 and -2.09 kg in the low-, mid- and high-volume groups, respectively. Similarly, weight loss was -1.47, -1.83, -2.21 kg in the low-, mid- and high-volume groups, respectively, compared to controls, and intra-abdominal fat area loss was -7.44, -15.56 and -8.76 cm2 in the low-, mid- and high-volume groups, respectively, compared to controls. No evidence for a dose-response effect on fat-free mass was noted. CONCLUSION: A dose-response effect of exercise volume on adiposity markers was noted, however, the differences in adiposity markers were smaller when comparing 225 min/week to 300 min/week of exercise. Given the strong positive associations between obesity and postmenopausal breast cancer risk, this study provides evidence on the importance of exercise volume as part of the exercise prescription to reduce adiposity and, ultimately, postmenopausal breast cancer risk.
BACKGROUND/ OBJECTIVE: Exercise may reduce the risk of breast cancer through adiposity changes, but the dose-response effects of exercise volume on adiposity markers are unknown in postmenopausal women. We aimed to compare the dose-response effects of prescribed aerobic exercise volume on adiposity outcomes. PARTICIPANTS/ METHODS: Data from the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) and Breast Cancer and Exercise Trial in Alberta (BETA) were pooled for this analysis (N = 720). These were 12-month randomized controlled trials, where participants were randomized to 225 min/week (mid-volume) of aerobic exercise versus usual inactive lifestyle (ALPHA), or 150 min/week (low-volume) versus 300 min/week (high-volume) (BETA). Fat mass and fat-free mass were measured using DXA and intra-abdominal and subcutaneous fat area were assessed with computed tomography. RESULTS: After 12 months of aerobic exercise, increasing exercise volumes from no exercise/control to 300 min/week resulted in statistically significant reductions in BMI, weight, fat mass, fat percentage, intra-abdominal and subcutaneous fat area (P < 0.001). Compared with controls, fat mass loss was -1.13, -1.98 and -2.09 kg in the low-, mid- and high-volume groups, respectively. Similarly, weight loss was -1.47, -1.83, -2.21 kg in the low-, mid- and high-volume groups, respectively, compared to controls, and intra-abdominal fat area loss was -7.44, -15.56 and -8.76 cm2 in the low-, mid- and high-volume groups, respectively, compared to controls. No evidence for a dose-response effect on fat-free mass was noted. CONCLUSION: A dose-response effect of exercise volume on adiposity markers was noted, however, the differences in adiposity markers were smaller when comparing 225 min/week to 300 min/week of exercise. Given the strong positive associations between obesity and postmenopausal breast cancer risk, this study provides evidence on the importance of exercise volume as part of the exercise prescription to reduce adiposity and, ultimately, postmenopausal breast cancer risk.
Authors: Marian L Neuhouser; Aaron K Aragaki; Ross L Prentice; JoAnn E Manson; Rowan Chlebowski; Cara L Carty; Heather M Ochs-Balcom; Cynthia A Thomson; Bette J Caan; Lesley F Tinker; Rachel Peragallo Urrutia; Jennifer Knudtson; Garnet L Anderson Journal: JAMA Oncol Date: 2015-08 Impact factor: 31.777
Authors: Irene Lambrinoudaki; Marc Brincat; C Tamer Erel; Marco Gambacciani; Mette H Moen; Karin Schenck-Gustafsson; Florence Tremollieres; Svetlana Vujovic; Margaret Rees; Serge Rozenberg Journal: Maturitas Date: 2010-07 Impact factor: 4.342
Authors: Kristin L Campbell; Karen E Foster-Schubert; Catherine M Alfano; Chia-Chi Wang; Ching-Yun Wang; Catherine R Duggan; Caitlin Mason; Ikuyo Imayama; Angela Kong; Liren Xiao; Carolyn E Bain; George L Blackburn; Frank Z Stanczyk; Anne McTiernan Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544
Authors: Samar R El Khoudary; Gail Greendale; Sybil L Crawford; Nancy E Avis; Maria M Brooks; Rebecca C Thurston; Carrie Karvonen-Gutierrez; L Elaine Waetjen; Karen Matthews Journal: Menopause Date: 2019-10 Impact factor: 2.953
Authors: Manuel Picon-Ruiz; Cynthia Morata-Tarifa; Janeiro J Valle-Goffin; Eitan R Friedman; Joyce M Slingerland Journal: CA Cancer J Clin Date: 2017-08-01 Impact factor: 508.702